National
Prop 8 plaintiffs lead Calif. couples in tying the knot
Ninth Circuit lifts stay on marriage equality; Anti-gay groups cry foul but are dismissed

Attorney General Kamala Harris marries Prop 8 plaintiffs Kris Perry and Sandy Stier (Blade screenshot by Chris Johnson)
The jubilation following two Supreme Court decisions in favor of marriage equality continued on Friday as plaintiffs in the lawsuit against California’s Proposition 8 became the first in the Golden State to marry after the demise of the ban on same-sex marriage.
The lesbian couple in lawsuit — Kris Perry and Sandra Stier — was first to marry in California and did so at 4:45 pm in a San Francisco City Hall ceremony officiated by California Attorney General Kamala Harris.
Shortly thereafter at 6:15 pm, the gay male couple — Paul Katami and Jeff Zarrillo — married in Los Angeles in a ceremony over which Los Angeles Mayor Antonio Villaraigosa officiated during his last day in office.
During the ceremony for Perry and Stier, Harris noted the long road on which the couple had journeyed since they filed their lawsuit in 2009 to restore marriage equality to California. Their son, Elliott Perry, served as a witness.
“Four years ago, Kris and Sandy embarked upon a journey that most couples do not experience,” Harris said. “By joining the case against Proposition 8, they represented thousands of couples like themselves in the fight for marriage equality.”
San Francisco City Hall stayed open until 8 pm to issue marriage licenses and will reopen from 9 am to 5pm Saturday and Sunday while the city celebrates June as Pride month.
Same-sex weddings resumed in California in the same city hall where nearly a decade ago then-San Francisco Mayor Gavin Newsom jump started the marriage equality movement by handing out marriage licenses to same-sex couples before the court ordered him to stop.
The weddings were able to commence in California thanks to the U.S. Ninth Circuit of Appeals lifting its stay on the injunction that U.S. District Judge Vaughn Walker put in place in 2010 prohibiting the enforcement of Prop 8. The lifting of stay was the consequence of the U.S. Supreme Court determination that anti-gay groups lack standing to defend Prop 8 in court.
In between the ceremonies for lesbian and the gay male couple, the plaintiffs held a conference call with reporters to talk about the jubilation they felt over finally being able to marry. They were joined by Chad Griffin, president of the Human Rights Campaign, and American Foundation for Equal Rights attorney Ted Boutrous.
Griffin said “we are all more American” on the day marriage equality resumed in California and emphasized gay nuptials in the Golden State are here to stay.
“Marriage has finally returned to the great state of California, and no one — no judge, no election and no politician — can take it away,” Griffin said.
Asked by the Washington Blade how it feels to finally be married after the completion of the lawsuit, Perry said she needs to wait until tomorrow for it to register.
“Right now, we feel victorious and thrilled and relieved, really, to be at the end of this long journey, and now finally able to move forward as a regular married couple just like everybody else,” Perry said.
Katami said he doesn’t much more to add as he prepared for his wedding ceremony, but noted the feeling of finally being able to marry was satisfying.
“I can tell you this: equal feels different,” Katami said. “We woke up on Thursday and this morning feeling like full citizens that will be recognized by our state, and recognized by our federal government. And we know that in just a few short minutes, Jeff and I will be able to call each other husband officially.”
In response to a question on whether plaintiffs received any advanced notice that the Ninth Circuit would lift its stay, advocates said on the call they had none but were nonetheless ready to spring into action when it happened.
But amid the excitement, anti-gay forces cried foul over what they said was a breach of protocol by the U.S. Ninth Circuit Court of Appeals in lifting the stay prematurely.
Legal observers had said they had a 25-day waiting period after the Supreme Court ruling in which proponents of Prop 8 could file for reconsideration. Even so, reconsideration is either rarely granted or never happens.
Andrew Pugno, an attorney with ProtectMarriage.com, posted a statement called the lifting of the stay an “outrageous act” and said the resumption of same-sex marriage has been obtained “by illegitimate means.”
“Homosexual marriage is not happening because the people changed their mind,” Pugno said. “It isn’t happening because the appellate courts declared a new constitutional right. It’s happening because enemies of the people have abused their power to manipulate the system and render the people voiceless.”
It’s unclear what recourse, if any, anti-gay forces have to fight the lifting of the stay after the Supreme Court determined they lack standing in court. Pugno said “it remains to be seen whether the fight can go on” as he said the development made for “a disgraceful day.”
LGBT advocates strongly pushed back on the notion that anti-gay forces had more options.
Asked by the Blade about this concern, Boutrous said Ninth Circuit “quite correctly” viewed itself as having the power to lift the stay and is “totally authorized by the court’s rules and by federal rules.”
“We’ve had cases where courts have lifted the stay in much more boring cases than this one,” Boutrous said. “And it makes sense here because you look at the possibility of success for the other side: it’s zero.”
Asked by another reporter if the Supreme Court or en banc panel of the Ninth Circuit could issue a stay if Prop 8 proponents asked for one during the 25-day waiting period, Boutrous said “no” because the high court determined the Ninth Circuit has no jurisdiction in the case.
Boutrous also dismissed another question on whether Prop 8 proponents could take action in state court, noting the federal injunction against Prop 8 would trump anything from state judges.
Those on the call also had no comment on what would happen if certain counties refused to hand marriage licenses to gay couples, referring a question on the matter from Reuters to the attorney general’s office.
The reaction from Stier was more mirthful in response to a question on what plans she and Perry had for a honeymoon.
“We didn’t have a lot of time to plan one, as you might well imagine, because we were at work when we found out we could get married today,” Stier said. “But next on our order of things to plan are a celebration, which means a reception, and then we need a honeymoon.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
